Mexico has emerged as a center for individuals seeking stem cell therapies. The country offers relatively lower costs compared to first-world nations, attracting patients from around the globe. This proliferation in stem cell tourism has sparked discussion regarding the success rate of these treatments and the stringency governing them. While so